Case Report: Treatment of Chromoblastomycosis with Combinations including Acitretin: A Report of Two Cases
Carregando...
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER SOC TROP MED & HYGIENE
Autores
Citação
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, v.103, n.5, p.1852-1854, 2020
Resumo
Chromoblastomycosis is a cutaneous fungal infection caused by dematiaceous fungi that belong to the order Chaetothyriales and family Herpotrichiellaceae. This infection is prevalent in tropical and subtropical areas and has been designated as a neglected tropical disease according to the WHO. Chromoblastomycosis infection is difficult to treat, and there are limited therapeutic options, making urgent the characterization of new medicines or approaches to treat such infection. In the present case report, two patients with extensive chromoblastomycosis lesions were treated with the combination of itraconazole, acitretin, and imiquimod. In the fourth month of treatment, both patients showed improvement of verrucous plates, suggesting that acitretin combined with drugs already used in chromoblastomycosis therapy can decrease the time of treatment, improving patient's quality of life.
Palavras-chave
Referências
- Bao FF, 2018, AM J TROP MED HYG, V99, P124, DOI 10.4269/ajtmh.17-0579
- Belda W, 2020, J DERMATOL, V47, P409, DOI 10.1111/1346-8138.15225
- Bonifaz A, 2004, EXPERT OPIN PHARMACO, V5, P247, DOI 10.1517/eoph.5.2.247.26473
- de Brito AC, 2018, AN BRAS DERMATOL, V93, P495, DOI 10.1590/abd1806-4841.20187321
- Dogra S, 2013, J EUR ACAD DERMATOL, V27, pe305, DOI 10.1111/j.1468-3083.2012.04644.x
- Esterre P, 1999, ANN PATHOL, V19, P516
- Gon ADS, 2006, INT J DERMATOL, V45, P1331, DOI 10.1111/j.1365-4632.2006.02757.x
- Pai VV, 2019, INDIAN J DERMATOL, V64, P213, DOI 10.4103/ijd.IJD_300_18
- Porras-Lopez C, 2019, AN BRAS DERMATOL, V94, P574, DOI 10.1016/j.abd.2019.09.014
- Queiroz-Telles F, 2013, MYCOPATHOLOGIA, V175, P477, DOI 10.1007/s11046-013-9648-x
- Queiroz-Telles F, 2009, MED MYCOL, V47, P3, DOI 10.1080/13693780802538001
- Shen XC, 2020, DERMATOLOGY THER, V10, P321, DOI 10.1007/s13555-020-00358-y
- de Sousa MDT, 2014, CLIN INFECT DIS, V58, P1734, DOI 10.1093/cid/ciu168
- WHO, 2020, END NEGL ATT SUST DE